Ginkgo Bioworks Holdings, Inc. / Fundamentals
Income statement
- Net revenue
€199.10M - Cost of goods sold
€35.45M - Gross profit
€163.65M - SG&A expenses
€174.17M - R&D expenses
€239.52M - EBITDA
-€270.24M - D&A
€55.19M - EBIT
-€270.27M - Interest expenses
€81.08K - EBT
-€272.66M - Tax expenses
-€772.02K - Net income
-€271.88M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€21.82M - Changes in working capital
-€33.03M - Operating cash flow
-€205.05M - Capex
€31.45M - Other investing cash flow
€1.25M - Net investing cash flow
-€246.58M - Total cash dividends paid
€0.00 - Issuance of common stock
-€72.46K - Debt repayment
-€610.71K - Other financing cash flow
-€228.59K - Net financing cash flow
-€839.30K - Foreign exchange effects
-€1.42M - Net change in cash
-€453.88M - Cash at end of period
€185.04M - Free cash flow
-€173.60M
Balance sheet
- Cash and cash equivalents
€175.59M - Cash and short-term investments
€408.60M - Total receivables
€19.95M - Inventory
€0.00 - Other current assets
€22.61M - Total current assets
€451.16M - Property, plant & equipment
€484.90M - Goodwill
€0.00 - Intangible assets
€57.06M - Long-term investments
€28.17M - Other non-current assets
€40.56M - Total non-current assets
€610.70M - Total assets
€1.06B - Accounts payable
€9.66M - Short-term debt
€0.00 - Other current liabilities
€49.37M - Total current liabilities
€83.43M - Long-term debt
€369.90M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€79.80M - Total non-current liabilities
€449.70M - Total liabilities
€533.13M - Common stock
€5.18K - Retained earnings
-€5.17B - Other equity
€1.43M - Total equity
€528.73M - Total liabilities and shareholders' equity
€1.06B
Company information
- Market capitalization
€472.29M - Employees
834 - Enterprise Value
€674.97M
Company ratios
- Gross margin
-
82.2% Much worse than peer group: 69,671,672,766,406,660,000.0% - EBITDA margin
-
-135.7% Much worse than peer group: 6,727,255,363,458,239,000.0% - EBIT margin
-
-135.7% Much worse than peer group: 5,768,379,317,568,478,000.0% - EBT margin
-
-136.9% Much worse than peer group: 7,049,282,613,071,101,600.0% - Net margin
-
-136.6% Much worse than peer group: 7,049,282,613,071,101,600.0% - ROE
-
-51.4% Much better than peer group: -1,106.6% - ROA
-
-25.6% Much better than peer group: -1,075.9% - Asset turnover
-
18.8% Even with peer group: 22.5% - FCF margin
-
-118.8% Much worse than peer group: 3,993,363,195,360,085,000.0% - FCF yield
-50.1% - Efficiency ratio
235.7% - Net sales per employee
-
€238.73K - Net income per employee
-
-€326.00K